Turn Cancer
Against Itself

What is the Holy Grail in cancer?

Kill the bad cells,
but don't kill the good cells

"Malignant growth and normal growth are so genetically intertwined that  unbraiding  the two might be one of the most  significant  scientific challenges faced  by our species ."

Prologue in The Emperor Of All Maladies
Pulitzer Prize 2011, Siddhartha Mukherjee

Earli designs programmable genetic constructs that turn on only in cancer cells and  force  them to  reveal,
and ultimately  kill  themselves.

See Earli's science →
Genetic Engineering & Biotechnology News: Earli Detection: “Synthetic” Biomarkers Light Up Hidden...
April 11, 2024
Newsweek: One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths | Opinion
May 10, 2023
WIRED: A Proactive Way to Detect Cancer at Its Earliest Stages
December 10, 2022
Fast Company: A Cancer Genius Died From Cancer. His Startup is Getting Revenge
December 13, 2021
Pharmaceutical Technology: Accenture Invests in Earli to Advance Early Cancer Detection Tech
CGT Live: Using DNA Nanoplasmids as a Diagnostic Tool in Cancer
The Sydney Morning Herald: Australia’s ‘High Quality’ Clinical Trials Lure Silicon Valley...
April 5, 2022
World Economic Forum: World Economic Forum Names Earli A Global Innovator
June 7, 2021
Fast Company: World Changing Ideas - Earli The Only Early Cancer Detection Firm in List of 2021
May 4, 2021
Tough Tech Today: Exposing Cancer, Feat. Cyriac Roeding of Earli
March 22, 2021
German Business Week (Wirtschaftswoche): The Inventor Is Dead, Long Live The Invention (German)
January 29, 2021
Forbes: This Company Raised $40 Million To Make Tumors Reveal Themselves
January 12, 2021
Business Wire: Earli Raises $40 Million Series A Funding Led by...
October 11, 2021
Study Pages: Seeking Dogs with Cancer to Assess Safety & Tolerability of a Novel Product Design...
September 1, 2020
The Atlantic: A Medical Revolution Too Late for the Man Who Started It
October 20, 2020
Stat News: New Ways to Detect Cancer Early Will Help Pave The Way for Precision Health
March 4, 2019